Intracellular Reactive Oxygen Species Mediate the Linkage of Na+/K+-ATPase to Hypertrophy and its Marker Genes in Cardiac Myocytes by Shapiro, Joseph I. et al.
Marshall University
Marshall Digital Scholar
Pharmaceutical Science and Research Faculty Research
Summer 7-2-1999
Intracellular Reactive Oxygen Species Mediate the
Linkage of Na+/K+-ATPase to Hypertrophy and
its Marker Genes in Cardiac Myocytes
Joseph I. Shapiro
Amir Askari
Zijian Xie
Peter Kometiani
Jie Li
See next page for additional authors
Follow this and additional works at: http://mds.marshall.edu/sp_psr
Part of the Medicinal and Pharmaceutical Chemistry Commons
This Article is brought to you for free and open access by the Faculty Research at Marshall Digital Scholar. It has been accepted for inclusion in
Pharmaceutical Science and Research by an authorized administrator of Marshall Digital Scholar. For more information, please contact
zhangj@marshall.edu.
Recommended Citation
Xie, Z., Kometiani, P., Liu, J., Li, J., Shapiro, J. I., & Askari, A. (1999). Intracellular reactive oxygen species mediate the linkage of
Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. Journal of Biological Chemistry, 274(27), 19323-19328.
Authors
Joseph I. Shapiro, Amir Askari, Zijian Xie, Peter Kometiani, Jie Li, and Jiang Liu
This article is available at Marshall Digital Scholar: http://mds.marshall.edu/sp_psr/31
Intracellular Reactive Oxygen Species Mediate the Linkage
of Na1/K1-ATPase to Hypertrophy and Its Marker Genes in
Cardiac Myocytes*
(Received for publication, January 20, 1999, and in revised form, April 7, 1999)
Zijian Xie‡, Peter Kometiani, Jiang Liu, Jie Li, Joseph I. Shapiro, and Amir Askari
From the Departments of Pharmacology and Medicine, Medical College of Ohio, Toledo, Ohio 43614
We showed before that in cardiac myocytes partial
inhibition of Na1/K1-ATPase by nontoxic concentra-
tions of ouabain causes hypertrophy and transcrip-
tional regulations of growth-related marker genes
through multiple Ca21-dependent signal pathways
many of which involve Ras and p42/44 mitogen-acti-
vated protein kinases. The aim of this work was to ex-
plore the roles of intracellular reactive oxygen species
(ROS) in these ouabain-initiated pathways. Ouabain
caused a rapid generation of ROS within the myocytes
that was prevented by preexposure of cells to N-acetyl-
cysteine (NAC) or vitamin E. These antioxidants also
blocked or attenuated the following actions of ouabain:
inductions of the genes of skeletal a-actin and atrial
natriuretic factor, repression of the gene of the a3-sub-
unit of Na1/K1-ATPase, activation of mitogen-activated
protein kinases, activation of Ras-dependent protein
synthesis, and activation of transcription factor NF-kB.
Induction of c-fos and activation of AP-1 by ouabain
were not sensitive to NAC. Ouabain-induced inhibition
of active Rb1 uptake through Na1/K1-ATPase and the
resulting rise in intracellular Ca21 were also not pre-
vented by NAC. A phorbol ester that also causes myocyte
hypertrophy did not increase ROS generation, and its
effects on marker genes and protein synthesis were not
affected by NAC. We conclude the following: (a) ROS are
essential second messengers within some but not all
signal pathways that are activated by the effect of oua-
bain on Na1/K1-ATPase; (b) the ROS-dependent path-
ways are involved in ouabain-induced hypertrophy; (c)
increased ROS generation is not a common response of
the myocyte to all hypertrophic stimuli; and (d) it may
be possible to dissociate the positive inotropic effect of
ouabain from its growth-related effects by alteration of
the redox state of the cardiac myocyte.
Na1/K1-ATPase (sodium pump) catalyzes the active trans-
port of Na1 and K1 across the plasma membranes of most
mammalian cells (1, 2). In the heart, partial inhibition of Na1/
K1-ATPase by ouabain and related cardiac glycosides causes a
modest increase in intracellular Na1, which in turn leads to
significant increases in intracellular Ca21 through the Na1/
Ca21 exchanger and in myocardial contractility through the
effects of Ca21 on contractile proteins (3). This effect on cardiac
contractility is the basis of the continued therapeutic use of
these drugs in the management of congestive heart failure (4,
5). Recently, we demonstrated that in cultured cardiac myo-
cytes the same nontoxic concentrations of ouabain that cause
partial inhibition of the sodium pump and increase intracellu-
lar Ca21 also stimulate hypertrophic growth and transcription-
ally regulate early- and late-response genes that are markers of
cardiac hypertrophy (6–8). This clearly indicated that the al-
tered activity of cardiac Na1/K1-ATPase by cardiac glycoside
drugs or by endogenous ouabain-like putative hormones (9)
must be considered as a potential signal for cardiac hypertro-
phy and its transition to failure, along with other hormonal,
mechanical, and pathological stimuli of hypertrophy (10).
While exploring the mechanism of linkage between the plasma
membrane sodium pump and four marker genes (c-fos and the
genes of skACT,1 ANF, and the a3 subunit of Na
1/K1-ATPase),
we also found that ouabain interaction with the pump initiates
multiple signal transduction cascades and that many of these
gene regulatory pathways involve activations of the GTP-bind-
ing protein Ras and p42/44 MAPKs (11).
ROS, such as the superoxide radical, the hydroxyl radical,
and H2O2, are continuously produced in most cells, and their
levels are regulated by a number of enzymes and physiological
antioxidants (12). It has been known for some time that exces-
sive generation of ROS is associated with cell injury in a variety
of pathological conditions including those of the cardiovascular
system (12). More recently, there has been rapidly growing
evidence indicating that ROS also have normal roles as second
messengers within several signal pathways involved in the
control of gene transcription (13–15). Because Ras has been
shown to be implicated in a number of such ROS-regulated
pathways (15–18) and in view of our findings on the central role
of Ras in ouabain-induced regulation of the growth-related
genes of cardiac myocytes (11), we were prompted to determine
the possible involvement of ROS in these ouabain effects. Here
we present the results of our initial studies showing that in-
tracellular ROS are indeed essential mediators of the ouabain-
induced hypertrophic phenotype and that antioxidants are ca-
pable of preventing the growth-related effects of ouabain in
cultured cardiac myocytes.
EXPERIMENTAL PROCEDURES
Materials—Chemicals of the highest purity available were obtained
from Sigma. TRI reagent for RNA isolation was from Molecular Re-* This work was supported by NHLBI National Institutes of Health
Grant HL-36573, by a grant-in-aid from the American Heart Associa-
tion, and by funds contributed in part by the American Heart Associa-
tion, Ohio-West Virginia Affiliate. The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Dept. of Pharmacol-
ogy, Medical College of Ohio, 3035 Arlington Ave., Toledo, OH 43614-
5804. Tel.: 419-383-4182; Fax: 419-383-2871; E-mail: ZXie@mco.edu.
1 The abbreviations used are: skACT, skeletal a-actin; ANF, atrial
natriuretic factor; CAT, chloramphenicol acetyltransferase; CM-DCF,
5-(and 6) chloromethyl-29,79-dichlorofluorescein; MAPK, mitogen-acti-
vated protein kinase; NAC, N-acetylcysteine; PMA, phorbol 12-myris-
tate 13-acetate; ROS, reactive oxygen species; MEK, mitogen-activated
protein kinase/extracellular signal-regulated kinase; CM-DCFH, re-
duced CM-DCF.
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search Center, Inc. (Cincinnati, OH). Radionucleotides (32P-labeled,
about 3000 Ci/mmol) and 86Rb1 were obtained from NEN Life Science
Products. [3H]Phenylalanine and the ECL kit were from Amersham
Pharmacia Biotech. Rabbit polyclonal Anti-ACTIVE MAPK pAb and
anti-p42/44 antibodies were obtained from Promega (Madison, WI) and
New England Biolabs (Beverly, MA), respectively. Fura-2 AM and CM-
DCFH diacetate were obtained from Molecular Probes (Eugene, OR).
Optitran and Nytran membranes were obtained from Schleicher and
Schuell.
Cell Preparation and Culture—Neonatal ventricular myocytes were
prepared and cultured as described in our previous work (6). Briefly,
myocytes were isolated from ventricles of 1-day-old Sprague-Dawley
rats and purified by centrifugation on Percoll gradients. Myocytes were
then cultured in a medium containing 4 parts of Dulbecco’s modified
Eagle’s medium and 1 part of Medium 199 (Life Technologies, Inc.),
penicillin (100 units/ml), streptomycin (100 mg/ml), and 10% fetal bo-
vine serum. After 24 h of incubation at 37 °C in humidified air with 5%
CO2, medium was changed to one with the same composition as above
but without the serum. All experiments were done after 48 h of further
incubation under serum-free conditions. These cultures contain more
than 95% myocytes as assessed by immunofluorescence staining with a
myosin heavy chain antibody.
Fluorescence Microscopic Measurements of Intracellular Ca21 Con-
centration and ROS Production—Myocytes were cultured on glass cov-
erslips. Intracellular Ca21 was measured by fura-2 as we previously
described (6). Fura-2 fluorescence was recorded using an Attofluor
imaging system (Atto Instruments) at an excitation wavelength of 340/
380 nm and at an emission wavelength of 505 nm. Under each experi-
mental condition time-averaged signals were obtained from about 40
single cells. Relative Ca21 concentration was calculated based on the
fluorescence ratio and Ca21 calibration curve (6). To measure intracel-
lular ROS production, cells were loaded with 10 mM CM-DCFH diac-
etate for 15 min at room temperature in the dark. The coverslip was
affixed to a culture chamber and perfused with the same culture me-
dium without phenol red. During loading the acetate groups on CM-
DCFH diacetate are removed by intracellular esterase, trapping the
probe inside the myocytes. Several dihydrofluorescein derivatives have
been used for measuring intracellular ROS generation (19–21). CM-
DCFH was chosen because it exhibited better retention in cells than
other derivatives. Production of ROS was measured by changes in
fluorescence because oxidation of CM-DCFH produced fluorescent prod-
uct CM-DCF in cardiac myocytes. Under each experimental condition
about 15 single myocytes were imaged with an Attofluor imaging sys-
tem (Atto Instruments), and CM-DCF fluorescence was measured at an
excitation wavelength of 480 nm and an emission wavelength of 520
nm.
Northern Blot—Northern blot was done as described previously (6–
8). Routinely, about 20 mg of total RNA was subjected to gel electro-
phoresis, transferred to a Nytran membrane, UV-immobilized, and
hybridized to 32P-labeled probes. Autoradiograms obtained at 270 °C
were scanned with a Bio-Rad densitometer. Multiple exposures were
analyzed to assure that the signals are within the linear range of the
film. The relative amount of RNA in each sample was normalized to
that of glyceraldehyde-3-phosphate dehydrogenase mRNA to correct for
differences in sample loading and transfer.
Measurement of Phosphorylation of p42/44 MAPKs—Activation of
p42/44 MAPKs in cultured myocytes was determined by Western blot
using a rabbit polyclonal antibody raised against dually phosphorylated
p42/44 MAPKs (11). In brief, after cells were exposed to ouabain,
reaction was terminated by the replacement of medium with 200 ml of
ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM NaF,
1 mM Na3VO4, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 50 mM
tetrasodium pyrophosphate, 10 nM okadaic acid, 1% Triton X-100,
0.25% sodium deoxycholate, 10 mg/ml aprotinin, and 10 mg/ml leupep-
tin). For Western blot analysis, cell lysates (60 mg/lane) were electro-
phoresed on 10% SDS-polyacrylamide gels and transferred to an Opti-
tran membrane. The membranes were probed with Anti-ACTIVE
MAPK pAb that detects p42/44 MAPKs only when they are activated by
phosphorylation at Thr202 and Tyr204. To ensure equal loading and
protein transfer, the same blots were stripped and probed with a poly-
clonal antibody recognizing both phosphorylated and nonphosphoryl-
ated p42/44 MAPKs. These membranes were developed with a second-
ary anti-rabbit antibody using the ECL method as instructed by the
manufacturer (Amersham Pharmacia Biotech). Autoradiograms were
scanned with a Bio-Rad densitometer to quantitate MAPK signals.
Assay of AP-1 Activation—A CAT reporter gene under the control of
three copies of the AP-1 cis-element (22) was kindly provided to us by
Dr. P. A. Baeuerle. Myocytes were transfected with 5 mg of plasmid
DNA using a modified calcium phosphate method (23). After 48 h of
incubation, the transfected cells were subjected to ouabain and other
treatments. Cell lysate was prepared and assayed for CAT as described
previously (24). All transfections were conducted in triplicate in 6.0-cm
tissue culture dishes. Control experiments with Rous sarcoma viruszb-
galactosidase reporter plasmid indicated that transfection efficiency
varied less than 15% within a given experiment under our experimental
conditions.
Detection of NF-kB by Immunofluorescence—This was done as de-
scribed before (35) using an antibody against the p65 subunit of NF-kB
(Santa Cruz Biotechnology).
Preparation of Replication-defective Adenovirus Asn17 Ras and Infec-
tion of Myocytes—The adenovirus expressing the dominant-negative
Ras was generated, amplified, and purified as described before (11). An
identical virus containing the b-galactosidase gene was used as virus
control. Myocytes were transduced by the same experimental proce-
dures used before (11). Under these conditions viral infection had no
effect on cell viability (11).
Protein Synthesis—Protein synthesis in these cultured myocytes was
assayed by [3H]phenylalanine incorporation as we previously described
(7). Cells were cultured in a 12-well plate, treated with ouabain and
other agents as indicated for 44 h, and continued for an additional 4 h
in the presence of 0.5 mCi of [3H]phenylalanine/well before total protein
and phenylalanine incorporation were assayed as indicated (7).
Assay of 86Rb1 Uptake by Myocytes—The initial rate of ouabain-
sensitive uptake of Rb1 through the Na1/K1-ATPase of the intact
myocytes was measured with modification of our previously described
procedures (6). Monensin (20 mM) was added to the medium prior to the
initiation of the Rb1 uptake assay to assure that the maximal capacity
of active uptake was measured (25).
Statistics—Data are given as mean 6 S.E. Statistical analysis was
performed using the Student’s t test, and significance was accepted at
p , 0.05.
RESULTS
Ouabain Increases Intracellular ROS in Cardiac Myo-
cytes—To determine if ouabain increases ROS production in
cardiac myocytes, cells were incubated with 10 mM CM-DCFH
diacetate for 15 min at room temperature in the dark, washed
with fresh medium, exposed to ouabain, and monitored for the
production of the fluorescent CM-DCF. As shown in Fig. 1,
FIG. 1. Time courses of the effects of varying ouabain concen-
trations on intracellular ROS production and the prevention of
these effects by NAC. Cardiac myocytes were loaded with the fluoro-
genic probe, exposed to ouabain (Ou), and assayed for the fluorescence
of the oxidized probe as indicated under “Experimental Procedures.”
When NAC was used, cells were incubated with it for 30 min prior to the
addition of ouabain. Each value is the mean 6 S.E. of determinations on
40–60 cells in four independent experiments.
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ouabain caused dose- and time-dependent increases in fluores-
cence, indicating stimulated ROS production in these cultured
myocytes. The highest ouabain concentration used was 100 mM
to avoid loss of viable cells (6). As expected, myocytes loaded
with the fluorogenic probe also exhibited increased fluores-
cence when exposed to H2O2 (data not shown). The maximal
fluorescence increase obtained with ouabain in experiments of
Fig. 1 was about the same as that produced by the addition of
2 mM H2O2. Preincubation of myocytes with the antioxidant
NAC (10 mM) suppressed the fluorescence increases induced by
ouabain (Fig. 1) and by H2O2 (not shown). Preincubation with
0.5 mM a-tocopherol (vitamin E) had about the same effect as
that of NAC shown in Fig. 1.
Effects of Antioxidants on the Gene Regulatory Effects of
Ouabain—The experiments shown in Figs. 2–6 were done to
assess the relation of the ouabain-induced generation of ROS to
the regulations of the four genes that we had previously shown
to be transcriptionally regulated by ouabain (6–8, 11). The
results showed that NAC blocked, in a dose-dependent manner,
the ouabain-induced increases in skACT and ANF mRNAs
(Figs. 2 and 3) and the ouabain-induced decrease in mRNA of
the a3-subunit of Na
1/K1-ATPase (Fig. 4). Experiments de-
picted in Fig. 5 showed that vitamin E and NAC similarly
antagonized the effects of ouabain on skACT, ANF, and a3-
subunit genes. In contrast to the antioxidant effects on these
late-response genes, induction of the early-response gene c-fos
by ouabain was not affected by either NAC (Fig. 6) or vitamin
E (not shown). The combined data of Figs. 2–6 clearly indicate
that ouabain initiates ROS-dependent and ROS-independent
gene regulatory pathways in these myocytes.
We showed before that induction of c-fos by ouabain is ac-
companied by an increase in the transcription factor AP-1,
which has been implicated in the regulation of cardiac growth-
related genes (6). In view of the lack of effect of NAC on the
induction of c-fos by ouabain (Fig. 6) but the known activation
of cardiac myocyte AP-1 by exogenous H2O2 (35), in the exper-
iments shown in Fig. 7 we examined the effects of ouabain and
NAC on myocytes that were transfected with a CAT gene
construct containing three AP-1 elements. Ouabain-induced
increase in CAT expression was also unaffected by NAC (Fig.
7), providing further support for the conclusion that some gene
regulatory effects of ouabain are through ROS-independent
pathways.
NF-kB is another transcription factor that, along with AP-1,
is regulated by the redox state in a variety of cell types (13–15,
34) and is known to be activated by exogenous H2O2 in cardiac
myocytes (35). Exposure of myocytes to ouabain caused the
nuclear translocation of the p65 subunit of NF-kB (Fig. 8),
indicative of its activation. Preincubation of myocytes with
NAC blocked this ouabain-induced translocation (Fig. 8), sug-
gesting a role of intracellular ROS in ouabain-induced activa-
tion of NF-kB.
In control experiments, the results of which are not shown, it
was established that antioxidants, at the concentrations and
FIG. 2. Effects of NAC on ouabain-induced expression of the
skACT gene. Cells were pretreated with NAC for 15 min, exposed to
ouabain (Ou) for 12 h, and assayed for mRNAs of skACT and glyceral-
dehyde-3-phosphate dehydrogenase as described under “Experimental
Procedures.” Values, normalized to those of corresponding glyceralde-
hyde-3-phosphate dehydrogenase, are mean 6 S.E. of five experiments.
FIG. 3. Effects of NAC on ouabain-induced expression of the
ANF gene. Experiments were done as in Fig. 2. Ou, ouabain.
FIG. 4. Effects of NAC on ouabain-induced down-regulation of
the gene of the a3-subunit of Na
1/K1-ATPase. Experiments were
done as in Fig. 2. Ou, ouabain.
FIG. 5. Comparison of NAC and vitamin E effects on ouabain-
induced regulations of the genes of ANF, skACT, and a3-subunit
of Na1/K1-ATPase. Cells were pretreated with 10 mM NAC or 0.5 mM
vitamin E for 15 min, exposed to 100 mM ouabain for 12 h, and assayed
for mRNAs as indicated under “Experimental Procedures.” A represent-
ative Northern blot of four different experiments is shown. Vit E,
vitamin E; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
FIG. 6. Lack of effect of NAC on ouabain-induced expression of
c-fos. Cells were pretreated with NAC for 30 min, exposed to ouabain
(Ou) for 45 min, and assayed for mRNAs as in Fig. 2. Values are mean 6
S.E. of three experiments.
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for the durations used in the experiments shown in Figs. 2–8,
had no significant effects on myocyte viability as measured by
lactate dehydrogenase release (6).
The Roles of Ras and ROS in Ouabain Stimulation of Protein
Synthesis—We showed before that nontoxic concentrations of
ouabain cause moderate hypertrophy of the myocytes as evi-
denced by ouabain-induced increases in total cell protein (6)
and in the rate of [3H]phenylalanine incorporation into cell
proteins (7). Because we had shown the involvement of Ras in
several signal pathways activated by ouabain (11), it was of
interest to know if Ras was also involved in the effect of oua-
bain on protein synthesis. Experiments depicted in Fig. 9
showed that the adenoviral-mediated expression of a domi-
nant-negative Ras blocked ouabain stimulation of [3H]pheny-
lalanine incorporation into myocyte proteins. Experiments of
Fig. 10 showed that ouabain stimulation of the protein synthe-
sis was also blocked by NAC. The combined data of Figs. 9 and
10 indicate that ouabain-induced hypertrophy, like ouabain-
induced regulations of the late-response genes (skACT, ANF,
and a3-subunit), involves both Ras and ROS. Interestingly,
NAC also significantly decreased the [3H]phenylalanine incor-
poration in the absence of ouabain (Fig. 10), suggesting that
basal levels of ROS may be important signals for the regulation
of protein synthesis.
Different Roles of ROS in Ouabain-induced and PMA-in-
duced Effects on Growth-related Genes and on Protein Synthe-
sis—PMA is a well established hypertrophic stimulus for the
cultured neonatal myocytes (6, 7, 26). Under the same condi-
tions where ouabain-induced effects on ANF and a3-subunit
genes were blocked by NAC, the antioxidant had no effect on
PMA-induced effects on the same genes (Fig. 11). Stimulation
of protein synthesis by PMA was also not blocked by NAC, in
contrast to the antioxidant effect on ouabain-stimulated pro-
tein synthesis (Fig. 10). In experiments similar to those shown
in Fig. 1, the same concentrations of PMA used the experi-
ments shown in Figs. 10 and 11 did not cause increased gen-
eration of ROS (data not shown). These results clearly show
that increased production of ROS is not a common response of
the cardiac myocytes to all hypertrophic stimuli.
Effect of NAC on Ouabain-induced Activation of p42/44
MAPKs—The antagonistic effects of antioxidants on ouabain-
induced actions, as noted in Figs. 2–10, occurred in experi-
ments with durations of several hours. On the other hand, the
rapid onset of the ouabain effect on the intracellular production
of CM-DCF (Fig. 1) suggested that increased generation of ROS
may represent an early event in ouabain-initiated signal trans-
duction pathways. Because the maximal activation of the Ras-
Raf-MEK-p42/44 MAPK cascade occurs within 5–15 min after
exposure to ouabain (11), it was of interest to examine the effect
of NAC on this rapid action of ouabain. Experiments depicted
in Fig. 12 showed that ouabain activation of p42 MAPK was
indeed attenuated by NAC.
NAC and Ouabain Effects on 86Rb1 Uptake and on Intracel-
lular Ca21—Because all of the hypertrophic and gene regula-
tory effects of ouabain are dependent on ouabain-induced inhi-
bition of the sodium pump and the resulting rapid rise in
FIG. 7. Lack of effect of NAC on ouabain-induced activation of
AP-1. Myocytes were transfected with a report CAT gene directed by
AP-1 elements, exposed to ouabain (Ou) for 16 h in the presence or
absence of NAC, and assayed for CAT as described under “Experimen-
tal Procedures.” Values are mean 6 S.E. of three experiments.
FIG. 8. Effect of NAC on ouabain-induced nuclear transloca-
tion of NF-kB. Immunostaining of myocytes with anti-p65 antibody
was done as indicated under “Experimental Procedures.” A, control
myocytes; B, myocytes treated with 100 mM ouabain for 1 h; C, myocytes
pretreated with 10 mM NAC for 30 min and then exposed to ouabain as
in B.
FIG. 9. Prevention of ouabain effect on protein synthesis by
dominant-negative Ras. Myocytes were transduced either with the
adenoviruses expressing an Asn17 dominant-negative mutant of Ras or
with the control virus containing the b-galactosidase (b-gal) gene for
12 h and then assayed for [3H]phenylalanine incorporation in the ab-
sence or presence of 100 mM ouabain (Ou) as indicated under “Experi-
mental Procedures.” Values are mean 6 S.E. of three experiments. *,
p , 0.05 against control.
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intracellular Ca21 (6–8, 11), we examined the combined effects
of NAC and ouabain on the transport function of the intact
myocyte Na1/K1-ATPase as measured by 86Rb1 uptake, and on
intracellular Ca21 concentrations of the cultured myocytes. In
experiments similar to those we have reported before (6), nei-
ther the maximal inhibitory effect of 1 mM ouabain nor the
partial inhibitory effect of 100 mM ouabain on the initial rate of
86Rb1 uptake was prevented or reduced by preincubation of
myocytes with 10 mM NAC for 15 min (data not shown). In
agreement with our previous results (6), 100 mM ouabain in-
creased intracellular Ca21 concentration from 89 6 18 nM to
167 6 24 nM. In myocytes that were pretreated with 10 mM
NAC, 100 mM ouabain raised Ca21 concentration from 104 6 25
nM to 191 6 34 nM.
DISCUSSION
The fact that ROS are second messengers within a variety of
intracellular signal transduction pathways has been indicated
by a large number of studies in cells other than cardiac myo-
cytes (13–18). The signaling roles of intracellularly generated
ROS in cardiac myocytes have been suggested by previous
studies when myocytes were subjected to hypoxia or hypoxia
reoxygenation (21, 27, 28) and when myocytes were exposed to
tumor necrosis factor-a or angiotensin II, two stimuli that
induce cardiac myocyte hypertrophy (29). Our findings pre-
sented here clearly establish the essential roles of ROS-regu-
lated signaling pathways in ouabain-induced hypertrophy, and
in transcriptional regulations of several growth-related genes
of these cardiac myocytes by ouabain. However, our findings
showing that PMA-induced hypertrophy does not involve ROS
also establish that increased intracellular generation of ROS is
not a requirement for the induction of myocyte hypertrophy per
se. Clearly, the potential signaling roles of ROS need to be
explored for each physiological and pharmacological stimulus
of cardiac hypertrophy to allow the determination of how the
various stimuli interact to cause pathological cardiac hypertro-
phy and to permit the assessment of the roles of ROS and
antioxidants in the development of cardiac hypertrophy and
failure.
Of particular interest are our findings on the different roles
of ROS in the ouabain-induced regulations of the four growth-
related genes. Although the regulations of three genes (those of
skACT, ANF, and the a3 subunit of Na
1/K1-ATPase) are de-
pendent on ROS generated in response to ouabain, these ROS
do not seem to be involved in the induction of c-fos by ouabain.
A plausible explanation for this apparent pathway specificity is
that within the complex network of multiple pathways acti-
vated by ouabain (11), the target of the generated ROS is not a
proximal component that is shared by all the pathways of the
network. Alternatively, because there are two branches within
the ouabain-activated pathways leading to the induction of
c-fos (11), it may be that repression of a ROS-regulated branch
is accompanied by a compensatory change in the activity of a
ROS-independent branch.
The nature and the source of the ouabain-induced ROS re-
main to be determined. Although available data suggest that
the fluorogenic compound used here for the detection of ROS is
more sensitive to H2O2 and the hydroxyl radical than to the
superoxide radical (21), the insufficient selectivity of the probe
and the interconversions of the generated ROS do not permit
firm conclusions on the nature of the species that act as second
messengers. In cells other than cardiac myocytes, mitochondria
and NADHzNADPH oxidase complexes, which include Rac as a
component, have been implicated as sources of signaling ROS
(15–17). In cardiac myocytes, mitochondria seem to be the
source of ROS involved in hypoxia-induced signaling (30). The
FIG. 10. Effects of NAC on ouabain-induced and PMA-induced
activations of protein synthesis. Myocytes exposed to the indicated
concentrations of ouabain (Ou), PMA, and NAC were assayed for
[3H]phenylalanine incorporation as described under “Experimental
Procedures.” Values are mean 6 S.E. of three experiments. *, p , 0.05
against control; **, p , 0.05 against 10 mM NAC.
FIG. 11. Lack of effect of NAC on PMA-induced regulations of
ANF (A) and a3-subunit (B) of Na1/K1-ATPase genes. Control and
NAC-treated cells were exposed to PMA and assayed for mRNAs as in
Fig. 2.
FIG. 12. Effect of NAC on ouabain-induced activation of p42
MAPK. Myocytes were pretreated with NAC for 30 min, exposed to
ouabain (Ou) for 15 min, and assayed for MAPK activation as described
under “Experimental Procedures.” Values are mean 6 S.E. of four
experiments.
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existence of a cytosolic NADH oxidase system responsible for
the production of superoxide in cardiac myocytes has also been
suggested (31), and the presence of Rac in cardiac myocytes has
been shown (32, 33). Because we have shown Ras activation to
be involved in all ouabain-initiated pathways (11) and because
others have implicated a signal cascade involving Ras-Rac in
the development of cardiac myocyte hypertrophy (33), it is
reasonable to suspect that a source of ouabain-induced ROS
generation may indeed be a Ras-Rac-NAD(P)H oxidase cas-
cade. Our studies on the relative roles of NAD(P)H complexes
and mitochondria as sources of ouabain-induced ROS are in
progress.
In the ouabain-initiated signal pathways, as in most ROS-
regulated pathways identified to date, the immediate targets of
ROS effects are not known. Our data showing that ouabain-
induced ROS production is antagonized by NAC and that oua-
bain-induced inhibition of Na1/K1-ATPase and the resulting
rise in intracellular Ca21 persist in the presence of NAC clearly
show that the generated ROS must affect the ouabain-initiated
pathways beyond the point where increased intracellular Ca21
affects all pathways (11). One such potential target is Ras,
because direct activation of Ras by ROS has been indicated by
studies on cells other than myocytes (18). This, coupled with
the likelihood of the Ras-Rac-oxidase cascade being the source
of the generated ROS, suggests the possible existence of a
signal amplification cycle within the ouabain-initiated and
ROS-regulated pathways. AP-1 and NF-kB, the two transcrip-
tion factors whose activations by ROS have been shown in a
large number of studies (13–15, 34), should also be considered
as potential downstream targets for any ROS-generating stim-
ulus. Although we have shown before that AP-1 is indeed
activated when cardiac myocytes are exposed to H2O2 (35), our
present findings (Fig. 7) argue against a role of ouabain-gen-
erated ROS in ouabain-induced activation of AP-1. NF-kB of
the cardiac myocytes, which is also activated by exogenous
H2O2 (35), is indeed a target of ouabain-generated ROS (Fig. 8).
The potential role of this transcription factor in the gene reg-
ulatory effects of ouabain needs further exploration.
Perhaps the most intriguing of our present findings is that in
the cultured myocytes it is possible to dissociate the effects of
ouabain on growth and growth-related genes from the classical
effect of the drug on the resting intracellular Ca21. Because the
latter is thought to be responsible for the effects of ouabain and
related cardiac glycosides on cardiac contractility (3), this
raises the important question of whether or not the redox state
of the myocyte or the intact heart can alter the effects of the
cardiac glycosides on cardiac hypertrophy without affecting the
positive inotropic effects of the drug. As discussed before (6), in
the context of the use of these drugs in the management of
heart failure, at this time it is not possible to say if the hyper-
trophic and the gene regulatory effects of the drugs will turn
out to be among their beneficial or undesirable effects.
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